who owns the patent for retatrutide Retatrutide, an investigational triple hormone receptor agonist that shows promise weight loss in ongoing phase-3 clinical trials, is being sold openly across internet and prescribed by licensed physicians online and Lilly, with new data, to

While prescription weight loss medications are generally well-tolerated, some people may experience mild side effects as their bodies adjust to treatment

In an extensive review of adverse event reports, dry mouth was far more common than expected for GLP-1 drugsabout 3 times higher than typical for semaglutide, and modestly higher for liraglutide and exenatide

Think of them as two different engines that power your body

Medications like Ozempic, Wegovy, and Mounjaro have become widely known for their effectiveness in weight management and metabolic health

While there is no problem with doing so, and we as medical professionals do actually recommend supplements in specific cases, this may not be the most optimal method for B12

Extra caution is needed for individuals with: A history of pancreatitis Certain gastrointestinal conditions Significant heart disease Pregnancy or plans to become pregnant A thorough medical evaluation helps determine whether retatrutide is a safe option